50 results
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
party shall have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties
S-3ASR
EX-4.6
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
of by the Trustee in accordance with its customary practices (subject to the record retention requirements of the Exchange Act).
SECTION 310. Computation of Interest … of the Securities, or the retention thereof by any Holder, if the Trustee did not have notice, as provided in this Section 1609, that such payment would have
S-3ASR
EX-4.4
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
in accordance with its customary practices (subject to the record retention requirements of the Exchange Act).
SECTION 310. Computation of Interest . Except
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
serve to:
ensure the attraction and retention of key management personnel;
ensure the motivation of management to achieve the Company’s corporate goals …
Designed to support Executive Directors in carrying out their duties and contribute to retention and recruitment.
The Company aims to offer benefits
PRE 14A
1lzf9zxmo pl
26 Apr 24
Preliminary proxy
4:36pm
8-K
EX-1.1
9lpkp2bh0 4k
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
DEFA14A
6jfrj
23 May 23
Additional proxy soliciting materials
4:08pm
8-K
pbxe oojxrgh9l3e556
8 Jul 22
Departure of Directors or Certain Officers
4:32pm
S-3
EX-4.4
tuii1fzn sid649mn1j4
1 Jul 22
Shelf registration
4:06pm